Wednesday 27 September
07.30-09.00 EDUCATIONAL TRACK SESSION 5 : INFECTION DISEASES
CHAIRS: Alain Le Moine, Brussels, Belgium
Frederike Bemelman, Amsterdam, The Netherlands
07.45 Prophylaxis of infections in solid organ transplantation (including donor derived infections)
Jay Alan Fishman, Boston, United States
08.00 Infectious diseases in the central nervous system of solid organ transplant patients
Peter Portegies, Amsterdam, The Netherland
08.15 Fungal and yeast Infections in SOT patients
José María Aguado, Madrid, Spain
08.30 Impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation
Oriol Manuel, Lausanne, Switzerland
07.30-09.00 EDUCATIONAL TRACK SESSION 6 : THE ALLOGRAFT PHENOTYPE AND ITS CLINICAL IMPLICATIONS
CHAIRS: Lorna Marson, Edinburgh, United Kingdom
Marlies Reinders, Leiden, The Netherlands
07.45 Allo-immune responses: what a clinician should know
Frans Claas, Leiden, The Netherlands
08.00 Rejection phenotypes across organs: revisiting the basics
Chris Bellamy, Edinburgh, United Kingdom
08.15 How to integrate complex histological phenotypes in routine clinical decision making?
Daniel Serón, Barcelona, Spain
08.30 Time to make computer-assisted instead of eminence-based decisions?
Alexandre Loupy, Paris, France
08.00-09.00 Full oral sessions
Brief oral sessions
09:10 - 10:40 STATE OF THE ART 7 | DONOR MANAGEMENT – CAN WE FURTHER EXTEND THE POTENTIAL DONOR POOL?
The prerequisite for successful transplantation is the availability of organs. At the same time, selecting suitable organs for transplantation is critical in order to guarantee optimal short- and long-term outcomes. During the last years, we have experienced an increasing interest in strategies to optimize donor management, especially since liberalization of donor criteria has been introduced within the field. In this session, we want to address the idea of further extending the potential donor pool. The focus will be recent innovative approaches and potential risk factors, that might limit further expansion. In this session we want to engage all professionals involved in this topic, including anaesthesiologists, intensivists, nurses, coordinators and transplant physicians in a lively exchange and discussion.
CREATED BY: Arne Neyrinck, Leuven, Belgium
Jacques Pirenne, Leuven, Belgium
CHAIRS: Arne Neyrinck, Leuven, Belgium
Jacques Pirenne, Leuven, Belgium
09.10 How controlled is my DCD?
Sophie Van Cromphaut, Leuven, Belgium
09.30 Should I perfuse my donor?
Simon Messer, Cambridge, United Kingdom
09.50 Tribulation in designing donor intervention studies
Claus Niemann, San Francisco, United States
10.10 How clean is my donor?
Margaret Hannan, Dublin, Ireland
09:10 - 10:40 STATE OF THE ART 8 | PUSHING THE BOUNDARIES IN LIVING DONATION
Live donation has become routine practice in many countries. The expansion of the acceptance criteria for live kidney donors is now challenged by emerging evidence for an increased relative risk for the development of renal failure on the long run. In this context, it is even more important how transplant professionals provide an individual risk assessments for potential donors. But how can we ensure that donors understand the potential risks? Do we have a good screening tool to assess potential psychological risks for live donors? Can we step away from standardized surgical approaches for live donor nephrectomy and adopt a tailor made approach? Should living donor liver transplantation be advocated to replace deceased donor liver Tx? This session focuses on the balance between pushing the limits in the context of potential short and long-term complications in this field.
CREATED BY: Frank Dor, London, United Kingdom
Gabriel Oniscu, Edinburgh, United Kingdom
CHAIRS: Barış Akin, Ankara, Turkey
Lisa Burnapp, Watford, United Kingdom
09.10 To be or not to be a donor - How can we make sure potential donors understand the risks?
Aisling Courtney, Belfast, Ireland
09.30 Psychosocial evaluation of live donors - the need for a tool to determine the psychological risk
Fabienne Dobbels, Leuven, Belgium
09.50 Tailor made live donor nephrectomy: a conversation between two surgeons
Frank Dor, London, United Kingdom and Gabriel Oniscu, Edinburgh, United Kingdom
10.10 Should live liver donor transplantation be advocated to substitute deceased donor liver Tx?
Yaman Tokat, Istanbul, Turkey
09:10 - 10:40 STATE OF THE ART 9 | CELLULAR INTERACTIONS IN REJECTION
Transplant rejection involves a coordinated attack of the graft by the recipient’s innate and the adaptive immune systems. Although direct visualization of this complex cellular interplay as made possible by recent technological progresses has greatly improved our understanding of rejection pathophysiology, it has also led to unexpected observations. Indeed, like in other chronic inflammatory conditions, organized lymphoid tissue develop in allografts. This session will provide an update on cellular interactions in rejection and will discuss whether intragraft tertiary lymphoid organs contribute to graft rejection and/or tolerance.
CREATED BY: Lorna Marson, Edinburgh, United Kingdom
Olivier Thaunat, Lyon, France
CHAIRS: Lorna Marson, Edinburgh, United Kingdom
Carla Baan, Rotterdam, The Netherlans
09.10 Visualizing cell trafficking and the underlying allosensitization by two-photon microscopy
Adrian Morelli (from T Starzl institute)
09.30 T-cell migration to vascularized transplants
Fadi Lakkis, Pittsburgh, United States
09.50 Lymphoid neogenesis: a tribute to the travelers
Nancy Ruddle, New Haven, United States
10.10 Intragraft tertiary lymphoid organs: friends and foes
Olivier Thaunat, Lyon, France
11:00 - 13:00 PLENARY SESSION 4 AND CLOSING | LEADERSHIP IN TRANSPLANTATION AND PRESIDENTIAL SESSION
Leadership is a key element in our professional lives, yet the attention to professionalism in this area has not received much attention. Much of the potential in our field could be mobilized by enhancing the understanding of the principles in modern leadership. In this final plenary session, you will hear from individuals within and outside of transplantation about their experience and their own views on leadership.
As per the tradition of the ESOT conference, you will also be presented with a summary of the most exciting innovations that have been discussed during the congress in this session.
CREATED BY: Lorna Marson, Edinburgh, United Kingdom
Stefan Schneeberger, Innsbruck, Austria
CHAIRS: Thierry Berney, Geneva, Switzerland; ESOT CURRENT PRESIDENT
Stefan Schneeberger, Innsbruck, Austria; ESOT PRESIDENT ELECT
11.00 Clinical: What's hot!
Dennis Hesselink, Rotterdam, The Netherlands
11.20 Basic Science: What's hot!
Oriol Bestard, Barcelona, Spain
11.40 Leadership in transplantation!
Dorry Segev, Baltimore, United States and Robert Montgomery, New York, United States
12.10 KEYNOTE Leadership
Javier Solana, Madrid, Spain
12.30 Presidential address
Stefan Schneeberger, Innsbruck, Austria